Home

PMV Pharmaceuticals, Inc. - Common Stock (PMVP)

1.4350
-0.0050 (-0.35%)

PMV Pharmaceuticals Inc is a biotechnology company focused on the discovery and development of novel therapies that target specific genetic mutations in cancer

The company utilizes its proprietary platform to identify and design small molecule drugs aimed at treating a range of cancers by addressing the underlying genetic drivers of the disease. With a strong emphasis on precision medicine, PMV Pharmaceuticals strives to improve patient outcomes through innovative treatments that can selectively target and inhibit tumor growth associated with particular genetic alterations.

SummaryNewsPress ReleasesChartHistoricalFAQ